Literature DB >> 20507339

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.

N Boudville1, C Inderjeeth, G J Elder, P Glendenning.   

Abstract

OBJECTIVE: Suboptimal levels of 25-hydroxyvitamin D (25OHD) are common in haemodialysis patients (Chronic Kidney disease-5D: CKD-5D) and may be associated with reduced muscle strength and increased falls risk. We tested the hypothesis that 25OHD levels may be independently associated with falls risk in CKD-5D.
BACKGROUND: Supplementation with calcium and cholecalciferol reduces hip and other nonvertebral fractures in elderly individuals, and this effect may in part be attributable to reduction in falls frequency. The relationship between 25OHD and falls risk has not been investigated in CKD-5D. DESIGN AND PATIENTS: This is a cross-sectional study of 25 CKD-5D patients with predialysis 25OHD, 1,25-dihydroxyvitamin D (1,25(OH)(2)D) and intact parathyroid hormone (iPTH) measurement. Falls risk was assessed by quadriceps muscle strength, FallsScreen((c)) test (FST), Berg Balance Scale (BBS), timed 'up and go' (TUG) test, Modified Barthel Index (MBI) and Falls Efficacy Scale (FES).
RESULTS: Mean age was 69.8 +/- 12.1 years, and median time on dialysis was 3.1 years. Median 25OHD level was 55.3 nmol/l (range 20.8-125.8 nmol/l). Muscle strength was significantly positively correlated with 25OHD (P = 0.024) but not with 1,25(OH)(2)D (P = 0.477) or PTH (P = 0.461). Statistically significant correlation between 25OHD levels and FST (P = 0.028) plus MBI (P = 0.0046) was noted. No significant correlation was detected between falls risk and 1,25(OH)(2)D or PTH.
CONCLUSIONS: Suboptimal levels of 25OHD in CKD-5D are associated with reduced quadriceps muscle strength and increased falls risk. 25OHD may be more important than the active renal metabolite 1,25(OH)(2)D for muscle strength with implications for vitamin D choice and goals of supplementation. Further investigation is required to examine effectiveness of calciferol supplementation on the incidence of falls in CKD-5D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507339     DOI: 10.1111/j.1365-2265.2010.03821.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  20 in total

1.  Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.

Authors:  Tanya M Wildes; Ronald J Maggiore; William P Tew; David Smith; Can-Lan Sun; Harvey Cohen; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cynthia Owusu; Cary P Gross; Hyman Muss; Andrew Chapman; Stuart M Lichtman; Vani Katheria; Arti Hurria
Journal:  Support Care Cancer       Date:  2018-04-28       Impact factor: 3.603

2.  Accidental falls and risk of mortality among older adults on chronic peritoneal dialysis.

Authors:  Janine Farragher; Ernest Chiu; Ozkan Ulutas; George Tomlinson; Wendy L Cook; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

3.  Mushroom Clouds for Vitamin D?

Authors:  Grahame J Elder
Journal:  J Am Soc Nephrol       Date:  2016-01-14       Impact factor: 10.121

4.  The Likelihood of Self-reporting Balance Problems in Those With Advanced Chronic Kidney Disease, Slow Gait Speed, or Low Vitamin D.

Authors:  Jordan F Wickstrom; Harlan R Sayles; Laura A Graeff-Armas; Jennifer M Yentes
Journal:  J Ren Nutr       Date:  2018-12-21       Impact factor: 3.655

5.  Falls among hemodialysis patients: potential opportunities for prevention?

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Haimanot Wasse
Journal:  Clin Kidney J       Date:  2014-04-15

6.  Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4.

Authors:  Patricia L Gordon; Julie W Doyle; Kirsten L Johansen
Journal:  J Ren Nutr       Date:  2012-01-09       Impact factor: 3.655

7.  Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Authors:  Nathan A Hewitt; Alicia A O'Connor; Denise V O'Shaughnessy; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

Review 8.  Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease.

Authors:  Yoshitsugu Obi; Takayuki Hamano; Yoshitaka Isaka
Journal:  Dis Markers       Date:  2015-03-26       Impact factor: 3.434

Review 9.  Renal disease and accidental falls: a review of published evidence.

Authors:  Pablo Jesús López-Soto; Alfredo De Giorgi; Elisa Senno; Ruana Tiseo; Annamaria Ferraresi; Cinzia Canella; María Aurora Rodríguez-Borrego; Roberto Manfredini; Fabio Fabbian
Journal:  BMC Nephrol       Date:  2015-10-29       Impact factor: 2.388

10.  Oral postdialysis cholecalciferol supplementation in patients on maintenance hemodialysis: a dose-response approach.

Authors:  Eric Descombes; Benoit Fellay; Ould Maouloud Hemett; Jean-Luc Magnin; Gilbert Fellay
Journal:  Int J Nephrol       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.